advertisement

News

USC Researchers Identify Key Mechanism That Guides Cells To Form Heart Tissue

Thursday, March 18, 2010

Los Angeles, Calif., March 16, 2010—Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key cellular mechanism that guides embryonic heart tissue formation—a process which, if disrupted, can lead to a number of common congenital heart defects.

Source: University of Southern California

Life Science News

MedInsight Research Institute

Baltimore, MD, 19 March 2010. – New research has revealed a major breakthrough...

Friday, March 19, 2010 Source: MedInsight Research Institute

Conventional Infection Control Measures Found Effective In Reducing MRSA Rates

Atlanta, Ga. (March 19, 2010)–Scientists at The Virginia Commonwealth University...

Friday, March 19, 2010 Source: Society for Healthcare Epidemiology of America

Pesticide Chlorpyrifos Is Linked To Childhood Developmental Delays

March 18, 2010—Exposure to the pesticide chlorpyrifos—which is banned for use in U.S...

Friday, March 19, 2010 Source: Columbia University's Mailman School of Public Health

Tryptophan-Enriched Diet Reduces Pig Aggression

Feeding the amino acid tryptophan to young female pigs as part of their regular...

Friday, March 19, 2010 Source: United States Department of Agriculture-Research, Education, and Economics

Females Shut Down Male-Male Sperm Competition In Leafcutter Ants

Leafcutter ant queens can live for twenty years, fertilizing millions of eggs...

Friday, March 19, 2010 Source: Smithsonian Tropical Research Institute

Manufacturing Antibodies

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific...

Friday, March 19, 2010 Source: EUREKA

Feedback Loop Explains Inflammatory Effect On Intestinal Lining

Signals released by immune cells during a bout of inflammatory bowel disease...

Friday, March 19, 2010 Source: Emory University
More Life Science News

Patent News

U.S. Patent And Trademark Office Grants Reissue Patent On Picoplatin Composition Of Matter

Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on innovative...

Thursday, March 18, 2010 Source: Poniard Pharmaceuticals, Inc.

Myriad Breast Cancer Patent Very Broad, Study Finds

Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly...

Wednesday, March 17, 2010 Source: Reuters

Epeius Biotechnologies Receives Notice Of Patent Allowance For Tumor-Targeted Cancer Vaccines

Epeius Biotechnologies Corporation, an emerging leader in the field of targeted...

Tuesday, March 16, 2010 Source: Epeius Biotechnologies
More Patent News

Clinical Trials News

Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program For NOV-002 In NSCLC; Primary And Secondary Endpoints Not Met In Phase 3 Trial

Novelos Therapeutics, Inc. (OTCBB: NVLT - News), a biopharmaceutical company...

Thursday, March 18, 2010 Source: BUSINESS WIRE

Protalix Initiates A Phase I Clinical Trial Of Acetylcholinesterase For Biodefense Indications

Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) announced today that it has...

Wednesday, March 17, 2010 Source: Protalix BioTherapeutics, Inc.

Single Short Course Of Tolerx's Otelixizumab Provides Prolonged Preservation Of Beta Cell Function

Tolerx, Inc., today announced the publication in Diabetologia, the journal of...

Tuesday, March 16, 2010 Source: Tolerx, Inc.
More Clinical Trials News

News Search

Search News By Keywords

News Sections

New Technologies

High Quality Antibodies
High Quality Antibodies
from Randox Laboratories Ltd.
IHC-plus(tm) Antibodies for Immunohistochemistry
IHC-plus™ Antibodies for...
from LifeSpan BioSciences
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading